
### [MONDO:0002637](http://purl.obolibrary.org/obo/MONDO_0002637)
**Label:** histiocytosis

**Subclasses:** [MONDO:0015532](http://purl.obolibrary.org/obo/MONDO_0015532) (generalized eruptive histiocytosis), [MONDO:0015531](http://purl.obolibrary.org/obo/MONDO_0015531) (non-Langerhans cell histiocytosis), [MONDO:0015534](http://purl.obolibrary.org/obo/MONDO_0015534) (juvenile xanthogranuloma), [MONDO:0015533](http://purl.obolibrary.org/obo/MONDO_0015533) (benign cephalic histiocytosis), [MONDO:0011871](http://purl.obolibrary.org/obo/MONDO_0011871) (Niemann-Pick disease type B), [MONDO:0011495](http://purl.obolibrary.org/obo/MONDO_0011495) (Langerhans-cell histiocytosis), [MONDO:0018982](http://purl.obolibrary.org/obo/MONDO_0018982) (Niemann-Pick disease type C), [MONDO:0009756](http://purl.obolibrary.org/obo/MONDO_0009756) (Niemann-Pick disease type A), [MONDO:0009757](http://purl.obolibrary.org/obo/MONDO_0009757) (Niemann-Pick disease, type C1), [MONDO:0004612](http://purl.obolibrary.org/obo/MONDO_0004612) (malignant histiocytosis), [MONDO:0007725](http://purl.obolibrary.org/obo/MONDO_0007725) (hereditary progressive mucinous histiocytosis), [MONDO:0009519](http://purl.obolibrary.org/obo/MONDO_0009519) (Letterer-Siwe disease), [MONDO:0001982](http://purl.obolibrary.org/obo/MONDO_0001982) (Niemann-Pick disease), [MONDO:0020384](http://purl.obolibrary.org/obo/MONDO_0020384) (Niemann-Pick disease type E), [MONDO:0016309](http://purl.obolibrary.org/obo/MONDO_0016309) (Niemann-Pick disease type C, juvenile neurologic onset), [MONDO:0015539](http://purl.obolibrary.org/obo/MONDO_0015539) (progressive nodular histiocytosis), [MONDO:0011873](http://purl.obolibrary.org/obo/MONDO_0011873) (Niemann-Pick disease, type C2), [MONDO:0016306](http://purl.obolibrary.org/obo/MONDO_0016306) (Niemann-Pick disease type C, severe perinatal form), [MONDO:0015536](http://purl.obolibrary.org/obo/MONDO_0015536) (papular xanthoma), [MONDO:0015535](http://purl.obolibrary.org/obo/MONDO_0015535) (xanthoma disseminatum), [MONDO:0016308](http://purl.obolibrary.org/obo/MONDO_0016308) (Niemann-Pick disease type C, late infantile neurologic onset), [MONDO:0015538](http://purl.obolibrary.org/obo/MONDO_0015538) (indeterminate cell histiocytosis), [MONDO:0016307](http://purl.obolibrary.org/obo/MONDO_0016307) (Niemann-Pick disease type C, severe early infantile neurologic onset), [MONDO:0015537](http://purl.obolibrary.org/obo/MONDO_0015537) (Necrobiotic xanthogranuloma), [MONDO:0015347](http://purl.obolibrary.org/obo/MONDO_0015347) (multicentric reticulohistiocytosis), [MONDO:0016310](http://purl.obolibrary.org/obo/MONDO_0016310) (Niemann-Pick disease type C, adult neurologic onset), [MONDO:0018153](http://purl.obolibrary.org/obo/MONDO_0018153) (Erdheim-Chester disease), [MONDO:0002984](http://purl.obolibrary.org/obo/MONDO_0002984) (reticulohistiocytic granuloma), [MONDO:0002346](http://purl.obolibrary.org/obo/MONDO_0002346) (malignant histiocytic disease), [MONDO:0004385](http://purl.obolibrary.org/obo/MONDO_0004385) (adult xanthogranuloma), [MONDO:0010017](http://purl.obolibrary.org/obo/MONDO_0010017) (sea-blue histiocyte syndrome), 

**Mapped go classes:** [GO:0006685](http://purl.obolibrary.org/obo/GO_0006685) (sphingomyelin catabolic process), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0030301](http://purl.obolibrary.org/obo/GO_0030301) (cholesterol transport), [GO:0070326](http://purl.obolibrary.org/obo/GO_0070326) (very-low-density lipoprotein particle receptor binding), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0046624](http://purl.obolibrary.org/obo/GO_0046624) (sphingolipid transporter activity), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0016242](http://purl.obolibrary.org/obo/GO_0016242) (negative regulation of macroautophagy), [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration), [GO:0035307](http://purl.obolibrary.org/obo/GO_0035307) (positive regulation of protein dephosphorylation), [GO:0071404](http://purl.obolibrary.org/obo/GO_0071404) (cellular response to low-density lipoprotein particle stimulus), [GO:0061750](http://purl.obolibrary.org/obo/GO_0061750) (acid sphingomyelin phosphodiesterase activity), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0043407](http://purl.obolibrary.org/obo/GO_0043407) (negative regulation of MAP kinase activity), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0046513](http://purl.obolibrary.org/obo/GO_0046513) (ceramide biosynthetic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0090150](http://purl.obolibrary.org/obo/GO_0090150) (establishment of protein localization to membrane), [GO:0042159](http://purl.obolibrary.org/obo/GO_0042159) (lipoprotein catabolic process), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0006665](http://purl.obolibrary.org/obo/GO_0006665) (sphingolipid metabolic process), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0007628](http://purl.obolibrary.org/obo/GO_0007628) (adult walking behavior), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0031579](http://purl.obolibrary.org/obo/GO_0031579) (membrane raft organization), [GO:0010873](http://purl.obolibrary.org/obo/GO_0010873) (positive regulation of cholesterol esterification), [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane), [GO:0000328](http://purl.obolibrary.org/obo/GO_0000328) (fungal-type vacuole lumen), [GO:0000324](http://purl.obolibrary.org/obo/GO_0000324) (fungal-type vacuole), [GO:0001540](http://purl.obolibrary.org/obo/GO_0001540) (amyloid-beta binding), [GO:0046889](http://purl.obolibrary.org/obo/GO_0046889) (positive regulation of lipid biosynthetic process), [GO:0071383](http://purl.obolibrary.org/obo/GO_0071383) (cellular response to steroid hormone stimulus), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0030516](http://purl.obolibrary.org/obo/GO_0030516) (regulation of axon extension), [GO:0004767](http://purl.obolibrary.org/obo/GO_0004767) (sphingomyelin phosphodiesterase activity), [GO:0006707](http://purl.obolibrary.org/obo/GO_0006707) (cholesterol catabolic process), [GO:0055113](http://purl.obolibrary.org/obo/GO_0055113) (epiboly involved in gastrulation with mouth forming second), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), [GO:0032374](http://purl.obolibrary.org/obo/GO_0032374) (regulation of cholesterol transport), [GO:0006486](http://purl.obolibrary.org/obo/GO_0006486) (protein glycosylation), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0023021](http://purl.obolibrary.org/obo/GO_0023021) (termination of signal transduction), [GO:0050750](http://purl.obolibrary.org/obo/GO_0050750) (low-density lipoprotein particle receptor binding), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0032366](http://purl.obolibrary.org/obo/GO_0032366) (intracellular sterol transport), [GO:0032367](http://purl.obolibrary.org/obo/GO_0032367) (intracellular cholesterol transport), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0034380](http://purl.obolibrary.org/obo/GO_0034380) (high-density lipoprotein particle assembly), [GO:0015485](http://purl.obolibrary.org/obo/GO_0015485) (cholesterol binding), [GO:1900221](http://purl.obolibrary.org/obo/GO_1900221) (regulation of amyloid-beta clearance), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0042220](http://purl.obolibrary.org/obo/GO_0042220) (response to cocaine), [GO:0006897](http://purl.obolibrary.org/obo/GO_0006897) (endocytosis), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005319](http://purl.obolibrary.org/obo/GO_0005319) (lipid transporter activity), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0046718](http://purl.obolibrary.org/obo/GO_0046718) (viral entry into host cell), [GO:0034372](http://purl.obolibrary.org/obo/GO_0034372) (very-low-density lipoprotein particle remodeling), [GO:0060228](http://purl.obolibrary.org/obo/GO_0060228) (phosphatidylcholine-sterol O-acyltransferase activator activity), [GO:0005774](http://purl.obolibrary.org/obo/GO_0005774) (vacuolar membrane), [GO:0042599](http://purl.obolibrary.org/obo/GO_0042599) (lamellar body), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0005773](http://purl.obolibrary.org/obo/GO_0005773) (vacuole), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0035855](http://purl.obolibrary.org/obo/GO_0035855) (megakaryocyte development), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle), [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0046686](http://purl.obolibrary.org/obo/GO_0046686) (response to cadmium ion), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:2000189](http://purl.obolibrary.org/obo/GO_2000189) (positive regulation of cholesterol homeostasis), [GO:0033700](http://purl.obolibrary.org/obo/GO_0033700) (phospholipid efflux), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 53.62%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.56%
- [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle) 51.56%
- [GO:0005775](http://purl.obolibrary.org/obo/GO_0005775) (vacuolar lumen) 51.56%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.56%
- [GO:0000328](http://purl.obolibrary.org/obo/GO_0000328) (fungal-type vacuole lumen) 51.56%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.92%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) 36.92%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.92%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 36.92%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 36.92%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 36.92%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 36.92%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 36.92%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 36.92%


